AllianceBernstein’s Vaxart VXRT Stock Holding History

AllianceBernstein’s Portfolio VXRT Stock Details VXRT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q2	–	Sell	-191,100	Closed	-$145K	–	3253
2023 Q1	$145K	Hold	191,100	–	–	﹤0.01%	2974
2022 Q4	$184K	Buy	191,100 +61,600	+48%	+$87.1K	﹤0.01%	3025
2022 Q3	$282K	Buy	129,500 +23,800	+23%	+$82.1K	﹤0.01%	2891
2022 Q2	$370K	Buy	105,700 +29,400	+39%	+$110K	﹤0.01%	2810
2022 Q1	$385K	Buy	76,300 +200	+0.3%	+$1.01K	﹤0.01%	2778
2021 Q4	$477K	Sell	76,100 -30,300	-28%	-$207K	﹤0.01%	2765
2021 Q3	$846K	Buy	106,400 +15,100	+17%	+$124K	﹤0.01%	2557
2021 Q2	$684K	Buy	91,300 +47,800	+110%	+$334K	﹤0.01%	2684
2021 Q1	$263K	Hold	43,500	–	–	﹤0.01%	2961
2020 Q4	$248K	Hold	43,500	–	–	﹤0.01%	2934
2020 Q3	$289K	Sell	43,500 -43,500	-50%	-$387K	﹤0.01%	2828
2020 Q2	$770K	Buy	+87,000	New	+$250K	﹤0.01%	2345

Other funds holding VXRT

Cantor Fitzgerald New York $6.78B AUM 29.01% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

RCMU

Rokos Capital Management (UK) London, United Kingdom $13.2B AUM 85.71% 1-Year Est. Return

AllianceBernstein's VXRT Position: Q2 2023 in Review

AllianceBernstein sold out of Vaxart (VXRT) in Q2 2023, closing a stake of 191,100 shares — an estimated $145K sold.

AllianceBernstein first reported a position in VXRT in Q2 2020 and held it in 12 quarters. The position peaked at $846K in Q3 2021. 111 funds tracked by Wall St. Rank hold VXRT as of Q2 2023.

AllianceBernstein reported no remaining Vaxart position as of Q2 2023 after selling out during the quarter.
AllianceBernstein sold 191,100 Vaxart shares in Q2 2023, an estimated $145K.
AllianceBernstein first reported a position in Vaxart in Q2 2020 and held it in 12 quarters.
AllianceBernstein's Vaxart position peaked at $846K in Q3 2021.
111 funds tracked by Wall St. Rank held Vaxart as of Q2 2023.

Based on AllianceBernstein's 13F filing for Q2 2023, filed 15 Aug 2023.